Neonatal Hemostatic Disorders: Issues and Challenges

 

 Buy Article Permissions and Reprints

Abstract

Neonates form a unique cohort with distinct features associated with the hemostatic system compared with older children and adults. The development of the human hemostatic system begins around 10 weeks in utero and continues to evolve during childhood. This dynamic period termed developmental hemostasis should be taken into consideration when diagnosing a neonate with disorders of bleeding or thrombosis.

^* The authors Santosh S. Hanmod and Rohith Jesudas have contributed equally to this article.

• References

• 1 Saracco P, Bagna R, Gentilomo C , et al; Neonatal Working Group of Registro Italiano Trombosi Infantili (RITI). Clinical Data of Neonatal Systemic Thrombosis. J Pediatr 2016; 171: 60-6.e1
  CrossrefPubMedGoogle Scholar
• 2 Soucie JM, Evatt B, Jackson D ; The Hemophilia Surveillance System Project Investigators. Occurrence of hemophilia in the United States. Am J Hematol 1998; 59 (4) 288-294
  CrossrefPubMedGoogle Scholar
• 3 Cade JF, Hirsh J, Martin M. Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn. BMJ 1969; 2 (5652) 281-283
  CrossrefPubMedGoogle Scholar
• 4 Monagle P, Massicotte P. Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med 2011; 16 (6) 294-300
  CrossrefPubMedGoogle Scholar
• 5 Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1 (2) 263-268
  CrossrefPubMedGoogle Scholar
• 6 Mandelbrot L, Guillaumont M, Leclercq M , et al. Placental transfer of vitamin K1 and its implications in fetal hemostasis. Thromb Haemost 1988; 60 (1) 39-43
  PubMedGoogle Scholar
• 7 Andrew M, Paes B, Milner R , et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70 (1) 165-172
  PubMedGoogle Scholar
• 8 Weinstein MJ, Blanchard R, Moake JL, Vosburgh E, Moise K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol 1989; 72 (1) 68-72
  CrossrefPubMedGoogle Scholar
• 9 Jilma-Stohlawetz P, Homoncik M, Jilma B , et al. High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol 2001; 112 (2) 466-468
  CrossrefPubMedGoogle Scholar
• 10 Corrigan Jr JJ, Sleeth JJ, Jeter M, Lox CD. Newborn's fibrinolytic mechanism: components and plasmin generation. Am J Hematol 1989; 32 (4) 273-278
  CrossrefPubMedGoogle Scholar
• 11 Monagle P, Barnes C, Ignjatovic V , et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95 (2) 362-372
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Coags Uncomplicated. Available at: https://www.coagsuncomplicated.com/Home.aspx . Accessed August 20, 2016
  PubMedGoogle Scholar
• 13 Stevens SM, Woller SC, Bauer KA , et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 2016; 41 (1) 154-164
  CrossrefPubMedGoogle Scholar
• 14 Klaassen IL, van Ommen CH, Middeldorp S. Manifestations and clinical impact of pediatric inherited thrombophilia. Blood 2015; 125 (7) 1073-1077
  CrossrefPubMedGoogle Scholar
• 15 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96 (5 Pt 1): 939-943
  PubMedGoogle Scholar
• 16 Thornburg CD, Smith PB, Smithwick ML, Cotten CM, Benjamin Jr DK. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res 2008; 122 (6) 782-785
  CrossrefPubMedGoogle Scholar
• 17 Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med 2006; 11 (3) 198-206
  CrossrefPubMedGoogle Scholar
• 18 Monagle P, Chan AK, Goldenberg NA , et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 ((2 Suppl):) e737S-801S
  CrossrefPubMedGoogle Scholar
• 19 Ergaz Z, Simanovsky N, Rozovsky K , et al. Clinical outcome of umbilical artery catheter-related thrombosis - a cohort study. J Perinatol 2012; 32 (12) 933-940
  CrossrefPubMedGoogle Scholar
• 20 Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002; 109 (1) 116-123
  CrossrefPubMedGoogle Scholar
• 21 Kirton A, Shroff M, Pontigon AM, deVeber G. Risk factors and presentations of periventricular venous infarction vs arterial presumed perinatal ischemic stroke. Arch Neurol 2010; 67 (7) 842-848
  PubMedGoogle Scholar
• 22 Raju TN, Nelson KB, Ferriero D, Lynch JK ; NICHD-NINDS Perinatal Stroke Workshop Participants. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007; 120 (3) 609-616
  CrossrefPubMedGoogle Scholar
• 23 Heller C, Heinecke A, Junker R , et al; Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003; 108 (11) 1362-1367
  CrossrefPubMedGoogle Scholar
• 24 Moharir MD, Shroff M, Pontigon AM , et al. A prospective outcome study of neonatal cerebral sinovenous thrombosis. J Child Neurol 2011; 26 (9) 1137-1144
  CrossrefPubMedGoogle Scholar
• 25 Winyard PJ, Bharucha T, De Bruyn R , et al. Perinatal renal venous thrombosis: presenting renal length predicts outcome. Arch Dis Child Fetal Neonatal Ed 2006; 91 (4) F273-F278
  CrossrefPubMedGoogle Scholar
• 26 Zigman A, Yazbeck S, Emil S, Nguyen L. Renal vein thrombosis: a 10-year review. J Pediatr Surg 2000; 35 (11) 1540-1542
  CrossrefPubMedGoogle Scholar
• 27 Morag I, Epelman M, Daneman A , et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148 (6) 735-739
  CrossrefPubMedGoogle Scholar
• 28 Williams S, Chan AK. Neonatal portal vein thrombosis: diagnosis and management. Semin Fetal Neonatal Med 2011; 16 (6) 329-339
  CrossrefPubMedGoogle Scholar
• 29 Morag I, Shah PS, Epelman M, Daneman A, Strauss T, Moore AM. Childhood outcomes of neonates diagnosed with portal vein thrombosis. J Paediatr Child Health 2011; 47 (6) 356-360
  CrossrefPubMedGoogle Scholar
• 30 Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219 (3) 645-650
  CrossrefPubMedGoogle Scholar
• 31 Auletta MJ, Headington JT. Purpura fulminans. A cutaneous manifestation of severe protein C deficiency. Arch Dermatol 1988; 124 (9) 1387-1391
  CrossrefPubMedGoogle Scholar
• 32 Price VE, Ledingham DL, Krümpel A, Chan AK. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med 2011; 16 (6) 318-322
  CrossrefPubMedGoogle Scholar
• 33 Rogenhofer N, Bohlmann MK, Beuter-Winkler P , et al. Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency. Ann Hematol 2014; 93 (3) 385-392
  CrossrefPubMedGoogle Scholar
• 34 Hirsh J, Anand SS, Halperin JL, Fuster V ; American Heart Association. AHA scientific statement: guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Arterioscler Thromb Vasc Biol 2001; 21 (7) E9-E9
  CrossrefPubMedGoogle Scholar
• 35 Kulkarni R. Bleeding in the newborn. Pediatr Ann 2001; 30 (9) 548-556
  CrossrefPubMedGoogle Scholar
• 36 Kulkarni R, Soucie JM, Lusher J , et al; Haemophilia Treatment Center Network Investigators. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from the Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia 2009; 15 (6) 1281-1290
  CrossrefPubMedGoogle Scholar
• 37 White II GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J ; Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001; 85 (3) 560
  Article in Thieme ConnectPubMedGoogle Scholar
• 38 Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004; 89 (6) F475-F478
  CrossrefPubMedGoogle Scholar
• 39 Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123 (6) 893-898
  CrossrefPubMedGoogle Scholar
• 40 Jaffray J, Young G, Ko RH. The bleeding newborn: A review of presentation, diagnosis, and management. Semin Fetal Neonatal Med 2016; 21 (1) 44-49
  CrossrefPubMedGoogle Scholar
• 41 Rare Coagulation Disorders Resource Room. Available at: http://www.rarecoagulationdisorders.org/ . Accessed August 20, 2016
  PubMedGoogle Scholar
• 42 Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125 (13) 2052-2061
  CrossrefPubMedGoogle Scholar
• 43 Simon D, Kunicki T, Nugent D. Platelet function defects. Haemophilia 2008; 14 (6) 1240-1249
  CrossrefPubMedGoogle Scholar
• 44 Zenciroglu A, Bas AY, Demirel N, Yarali N. Glanzmann thrombasthenia in a neonate. Indian Pediatr 2007; 44 (1) 40-42
  PubMedGoogle Scholar
• 45 Kenet G, Krümpel A, Nowak-Göttl U. Bleeding issues in neonates, infants and young children. Thromb Res 2009; 123 (Suppl. 02) S35-S37
  PubMedGoogle Scholar
• 46 Siboni SM, Zanon E, Sottilotta G , et al. Central nervous system bleeding in patients with rare bleeding disorders. Haemophilia 2012; 18 (1) 34-38
  PubMedGoogle Scholar
• 47 Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Körholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 1999; 158 (Suppl. 03) S162-S165
  CrossrefPubMedGoogle Scholar
• 48 Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008; 140 (4) 378-384
  CrossrefPubMedGoogle Scholar
• 49 Altisent C, Martorell M, Vidal F, Sánchez MA, Parra R. The optimal mode of delivery for the haemophilia carrier expecting an affected infant: further considerations. Haemophilia 2011; 17 (5) 818-819
  PubMedGoogle Scholar
• 50 Chalmers EA, Williams MD, Richards M , et al; Paediatric Working Party of Ukhcdo. Management of neonates with inherited bleeding disorders--a survey of current UK practice. Haemophilia 2005; 11 (2) 186-187
  CrossrefPubMedGoogle Scholar
• 51 Chalmers E, Williams M, Brennand J, Liesner R, Collins P, Richards M ; Paediatric Working Party of United Kingdom Haemophilia Centre Doctors' Organization. Guideline on the management of haemophilia in the fetus and neonate. Br J Haematol 2011; 154 (2) 208-215
  CrossrefPubMedGoogle Scholar
• 52 Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001; 112 (2) 264-274
  CrossrefPubMedGoogle Scholar
• 53 Srivastava A, Brewer AK, Mauser-Bunschoten EP , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (1) e1-e47
  CrossrefPubMedGoogle Scholar
• 54 Curnow J, Pasalic L, Favaloro EJ. Treatment of von Willebrand Disease. Semin Thromb Hemost 2016; 42 (2) 133-146
  Article in Thieme ConnectPubMedGoogle Scholar
• 55 Young G, Wicklund B, Neff P, Johnson C, Nugent DJ. Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. Pediatr Blood Cancer 2009; 53 (2) 179-183
  CrossrefPubMedGoogle Scholar
• 56 Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. J Pediatr Hematol Oncol 2013; 35 (3) 221-226
  CrossrefPubMedGoogle Scholar
• 57 Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol 2008; 25 (4) 301-311
  CrossrefPubMedGoogle Scholar
• 58 Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK. Pediatric off-label use of recombinant factor VIIa. Pediatrics 2009; 123 (3) 1066-1072
  CrossrefPubMedGoogle Scholar
• 59 Madan B, Street AM. What is the optimal mode of delivery for the haemophilia carrier expecting an affected infant-vaginal delivery or caesarean delivery?. Haemophilia 2010; 16 (3) 425-426
  PubMedGoogle Scholar
• 60 Nazir HF, Al Lawati T, Beshlawi I , et al. Mode of delivery and risk of intracranial haemorrhage in newborns with severe haemophilia A: a multicentre study in Gulf region. Haemophilia 2016; 22 (3) e134-e138
  CrossrefPubMedGoogle Scholar
• 61 Davies J, Kadir RA. Mode of delivery and cranial bleeding in newborns with haemophilia: a systematic review and meta-analysis of the literature. Haemophilia 2016; 22 (1) 32-38
  CrossrefPubMedGoogle Scholar
• 62 Economou M, Banov L, Ljung R. Perinatal aspects of haemophilia. Eur J Haematol Suppl 2014; 76: 21-25
  PubMedGoogle Scholar
• 63 Kulkarni R, Lusher JM. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol 1999; 21 (4) 289-295
  CrossrefPubMedGoogle Scholar
• 64 Nowak-Göttl U, Limperger V, Bauer A, Kowalski D, Kenet G. Bleeding issues in neonates and infants - update 2015. Thromb Res 2015; 135 (Suppl. 01) S41-S43
  CrossrefPubMedGoogle Scholar
• 65 Kamphuis MM, Paridaans NP, Porcelijn L, Lopriore E, Oepkes D. Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics 2014; 133 (4) 715-721
  CrossrefPubMedGoogle Scholar
• 66 McQuilten ZK, Wood EM, Savoia H, Cole S. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. Aust N Z J Obstet Gynaecol 2011; 51 (3) 191-198
  CrossrefPubMedGoogle Scholar
• 67 Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol 2013; 161 (1) 3-14
  CrossrefPubMedGoogle Scholar
• 68 Chakravorty S, Roberts I. How I manage neonatal thrombocytopenia. Br J Haematol 2012; 156 (2) 155-162
  CrossrefPubMedGoogle Scholar